US equities |
MU $1,043.37 ▼-2.04% NVDA $229.41 ▲+0.45% SNDK $1,730.65 ▼-0.53% AMD $609.41 ▼-0.38% INTC $119.70 ▼-0.44% TSLA $358.74 ▲+1.11% GOOGL $340.89 ▼-0.93% LITE $1,061.89 ▲+9.33%
FinancialContent Watchlist

Articles published by Mirum Pharmaceuticals

News headline image
Mirum’s LIVMARLI® Now Authorized in Canada for Cholestatic Pruritus in Patients with Alagille Syndrome
From Mirum Pharmaceuticals
Via Business Wire
Tickers MIRM